Whitepapers
Big Book of Clinical Trial Design
October 22 by Natasha TaylorMerck, GSK, NIHR, Arena Pharma and more offer practical case studies to help you navigate your next clinical trial journey
Computational Infrastructure for Modern Pharmaceuticals
June 19 by Alireza ShabaniThis paper, by Alireza Shabani, Founder & CEO of Qulab, describes the necessary computational architecture for pharmaceutical firms to accelerate R&D and drug discovery, especially utilizing special purpose silicon and quantum processors.
[Analysis] How Industry 4.0 tech could solve the biggest risks in single use manufacturing facilities
April 16 by Pharma IQBilly Sisk of Rockwell Automation shares how Industry 4.0 could transform one of the biggest risks in single use; human error
[Case Study] How Sanofi managed material compliance for 500 UK employees with just one app
April 09 by Pharma IQIn just three months, Sanofi automated over 600 approved materials and accounts following this process
Improving Pharma R&D efficiency
October 04 by Pharmaceuticals & Biotechnology EditorIn this report, Icon has identified key areas of improvement for pharmaceutical manufacturers looking to transform their approach to trials and R&D.
Opportunities for optimized preclinical development report
September 12 by Pharmaceuticals & Biotechnology EditorFocusing on the preclinical development process, cloud-based R&D innovators IDBS are finding ways to optimize pharmaceutical firms' development processes in a holistic manner.
Cyber Security in Pharma Report
June 19 by Chanice HenryExperts forecast that 2018 can expect cyber breaches only to get bigger with hackers and technologies getting smarter.
Outsourcing Trends in Pharma & Biotech eBook
May 29 by Pharma IQDownload this eBook to discover the key outsourcing trends impacting today's pharma and biotech industries.
Editorial Sponsorship Calendar
March 27 by Pharma IQ NewsPharma iQ's Editorial Sponsorship Calendar offers an effective, efficient and credible way to engage the global pharmaceutical and life science market.
5 dangerous data integrity risks your lab may be taking
February 01 by Bob McDowallRegulatory authorities like the FDA and MHRA expect pharma labs to constantly improve how they safeguard drug quality. There are many data integrity risks for labs to combat
Mythbuster: Advanced Analytics In Pharma
January 03 by Pharma IQPharma IQ takes a look at key tech buzzwords that have emerged in pharma on the back of drug discovery's digital transformation.
Boost productivity within biologics discovery and development
November 22 by Robert D Brown of DotmaticsThis whitepaper from Dotmatics demonstrates how research organizations can make their biologics discovery projects more efficient and enhance innovation with better informed decision making.